We describe an unusual family in which 2 adult siblings and the son of 1 are all affected by cystic fibrosis with rare mutations and different phenotypes. We discuss the dilemma surrounding the treatment of Pseudomonas aeruginosa colonization in the asymptomatic father, while minimizing disruption to the father–son relationship.
Get full access to this article
View all access options for this article.
References
1.
MoskowitzSM, ChmielJF, SternenDL, ChengE, GibsonRL, MarshallSG, CuttingGR. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med, 2008; 10:851–868.
2.
KeremE, CoreyM, KeremBS, RommensJ, MarkiewiczD, LevisonH, TsuiLC, DurieP. The relation between genotype and phenotype in cystic fibrosis—analysis of the most common mutation (delta F508). N Engl J Med, 1990; 323:1517–1522.
3.
TsuiLC, DurieP. Genotype and phenotype in cystic fibrosis. Hosp Pract (Off Ed), 1997; 32:115–118.
4.
CollacoJM, BlackmanSM, McGreadyJ, NaughtonKM, CuttingGR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr, 2010; 157:802–807.
5.
KosorokMR, ZengL, WestSE, RockMJ, SplaingardML, LaxovaA, GreenCG, CollinsJ, FarrellPM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol, 2001; 32:277–287.
6.
EmersonJ, RosenfeldM, McNamaraS, RamseyB, GibsonRL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol, 2002; 34:91–100.
7.
GreenDM, CollacoJM, McDougalKE, NaughtonKM, BlackmanSM, CuttingGR. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr, 2012; 161:290–295.
8.
KristidisP, BozonD, CoreyM, MarkiewiczD, RommensJ, TsuiLC, DurieP. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet, 1992; 50:1178–1184.
9.
StuhrmannM, DörkT. CFTR gene mutations and male infertility. Andrologia, 2000; 32:71–83.
10.
WrightFA, StrugLJ, DoshiVK, CommanderCW, BlackmanSM, SunL, BerthiaumeY, CutlerD, CojocaruA, CollacoJM, CoreyM, DorfmanR, GoddardK, GreenD, KentJWJr, LangeEM, LeeS, LiW, LuoJ, MayhewGM, NaughtonKM, PaceRG, ParéP, RommensJM, SandfordA, StonebrakerJR, SunW, TaylorC, VanscoyLL, ZouF, BlangeroJ, ZielenskiJ, O'NealWK, DrummML, DuriePR, KnowlesMR, CuttingGR. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet, 2011; 43:539–546.
11.
PetreskaL, KocevaS, Gordova-MuratovskaA, NestorovR, EfremovGD. Identification of two new mutations (711+3A—>G and V1397E) in CF chromosomes of Albanian and Macedonian origin. Hum Mol Genet, 1994; 3:999–1000.
12.
The Clinical and Functional Translation of CFTR (CFTR2). Available at http://cftr2.org.
NickJA, ChaconCS, BrayshawSJ, JonesMC, BarboaCM, St. ClairCG, YoungRL, NicholsDP, JanssenJS, HuittGA, IsemanMD, DaleyCL, Taylor-CousarJL, AccursoFJ, SaavedraMT, SontagMK. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med, 2010; 182:614–626.
15.
McCallumSJ, GallagherMJ, CorkillJE, HartCA, LedsonMJ, WalshawMJ. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax, 2002; 57:559–560.
16.
Abdul WahabA, Taj-AldeenSJ, HagenF, DiophodeS, SaadoonA, MeisJF, KlaassenCH. Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting. Eur J Clin Microbiol Infect Dis, 2014; 33:265–271.
17.
JonesAM, DoddME, GovanJRW, BarcusV, DohertyCJ, MorrisJ, WebbAK. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax, 2004; 59:948–951.
18.
SaimanL, SiegelJ. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol, 2003; 24:S6–S52.
19.
SaimanL. Infection prevention and control in cystic fibrosis. Curr Opin Infect Dis, 2011; 24:390–395.
20.
SaimanL. Update on infection prevention and control guidelines. Pediatr Pulmonol, 2013; 48:185–187.
21.
Raccomandazioni per la prevenzione ed il controllo delle infezioni da patogeni respiratori in Fibrosi Cistica Available at http://sifc.it
22.
FestiniF, BuzzettiR, BassiC, BraggionC, SalvatoreD, TaccettiG, MastellaG. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. J Hosp Infect, 2006; 64:1–6.
